Don't miss 'The Curse of Rigel ' Expansion Launch Trailer for Wartales, an open-world turn-based strategy RPG developed by Shiro Games. Players will enforce the King's will to venture into the County ...

Rigel Pharmaceuticals (RIGL) swung to profitability over the past year, growing its earnings at an impressive 40.2% annual rate over the last five years. The company’s net profit margin turned ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported net income of $27.9 million in its third quarter. On a per-share basis, the ...

Based on the one-year price targets offered by 6 analysts, the average target price for Rigel Pharmaceuticals Inc (NASDAQ:RIGL) is $38.33, with a high estimate of $67.00 and a low estimate of $23.00.

Shares of Rigel Pharmaceuticals (RIGL) have been strong performers lately, with the stock up 56.6% over the past month. The stock hit a new 52-week high of $30.43 in the previous session. Rigel has ...

Rigel Pharmaceuticals Inc. (RIGL) reported robust financial results for the second quarter of 2025, significantly boosting its revenue guidance for the year. The company’s stock surged 7.06% in ...

Rigel’s IRAK1/4 inhibitor, R289, has shown promising results in a Phase 1b trial for relapsed/refractory lower-risk myelodysplastic syndrome (LR-MDS). The initial data presented at ASH 2024 ...

Rigel Pharmaceuticals, Inc. shows strong momentum, with a 68% YoY revenue increase, driven by TAVALISSE, GAVRETO, and REZLIDHIA, suggesting a shift to a durable growth stock. Q1 net income of $11.4M ...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders are probably feeling a little disappointed, since its shares fell 9.6% to US$19.70 in the week after its latest annual results. It looks like a ...